RANI · Rani Therapeutics Holdings, Inc.

$0.88 +0.03 (+3.41%) At close · Aug 21

Market Cap

$122.67M

139.40M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Talat Imran	Chief Executive Officer	$198,325	—	—	$502,176	$351,600	—	$1,052,101
Svai Sanford	Chief Financial Officer	$392,711	$139,000	—	$154,993	$259,700	—	$946,404
Kate McKinley	Chief Business Officer	$370,472	$130,000	—	$201,565	$241,900	—	$943,937

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Talat Imran	Chief Executive Officer	$105,818	—	—	$2,936,227	—	—	$3,042,245
Mir Hashim	Chief Scientific Officer	$416,000	—	—	$875,456	—	—	$1,291,456
Svai Sanford	Chief Financial Officer	$416,000	—	—	$875,456	—	—	$1,291,456
Kate McKinley	Chief Business Officer	$390,000	—	—	$875,456	—	—	$1,265,456

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Talat Imran	Chief Executive Officer	$450,000	—	$1,923,040	$2,893,853	—	—	$5,266,893
Mir Hashim	Chief Scientific Officer	$416,000	—	$756,160	$996,166	—	—	$2,168,326
Svai Sanford	Chief Financial Officer	$416,000	—	$756,160	$983,836	—	—	$2,155,996

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Talat Imran	Chief Executive Officer	$515,000	—	$1,143,986	$2,340,204	$312,000	—	$4,311,190
Mir Hashim	Chief Scientific Officer	$412,000	—	$544,252	$1,114,129	$249,600	—	$2,319,981
Svai Sanford	Chief Financial Officer	$412,000	—	$434,609	$888,460	$249,600	—	$1,984,669

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Talat Imran	Chief Executive Officer	$408,333	—	—	$10,999,490	$375,000	—	$11,782,823
Mir Hashim	Chief Scientific Officer	$396,923	—	$2,300,256	$2,010,118	$300,000	—	$5,007,297
Svai Sanford	Chief Financial Officer	$375,737	—	$2,077,272	$1,918,675	$300,000	—	$4,671,684

Executive changes

Person	Role	Change	Effective	Filed
Michelle Gilson	Board	Appointed	2026-08-01	2026-08-04
Nicholas M. Maestas	Chief Financial Officer (principal financial officer and principal accounting officer)	Appointed	2026-06-29	2026-06-30
Abraham Bassan	member of the Board	Appointed	—	2025-10-27
Vasudev Bailey	member of the Board	Appointed	—	2025-10-27
Maulik Nanavaty	member of the Company's board of directors	Resigned	—	2025-10-27
Andrew Farquharson	member of the Company's board of directors	Resigned	—	2025-10-27
Laureen DeBuono	member of the Board	Retired	2025-04-24	2025-04-30
Lisa Rometty	director	Appointed	2022-01-03	2022-01-05
Lyn Baranowski	Director	Appointed	2021-11-10	2021-11-12

Key facts CIK 1856725 CUSIP 753018100 13F (30d) 62 filings 60 filers Visit website Investor relations